OcuNexus Therapeutics appoints Rajiv Shukla to its Board as Independent Director

– USA, CA –  OcuNexus Therapeutics, a clinical-stage biotechnology company developing a first-in-class orally administered treatment for the dry form of age-related macular degeneration and diabetic retinopathy, today announced that it has strengthened its board of directors with the addition of Rajiv Shukla, who has deep experience in the investment and commercial aspects of the pharmaceutical industry.…

ArunA Bio adds Tony Townley to its Board of Directors

– USA, GA –  ArunA Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced the addition of Tony Townley to its Board of Directors.…